# IeDEA Asia-Pacific Research Collaboration

> **NIH NIH U01** · FOUNDATION FOR AIDS RESEARCH · 2022 · $3,084,111

## Abstract

PROJECT SUMMARY/ABSTRACT
The Asia-Pacific region has struggled to keep up with global efforts to end AIDS as a public health threat by
2030. Only 60% of the 5.8 million people living with HIV (PLHIV) in the region are on antiretroviral therapy. In
addition, with high burdens of chronic hepatitis B and C and tuberculosis, and the emergence of COVID-19,
there is increasing local competition for limited health resources. In order to achieve long-lasting health gains
for Asia-Pacific PLHIV and move us closer to ending AIDS in the region, data-driven public health
approaches are needed that efficiently integrate clinical care and research across diseases, and target
communities at greatest risk of the poorest outcomes. Working with a network of over 50 clinical centers
in 13 countries, the IeDEA ASIA-PACIFIC RESEARCH COLLABORATION will implement a cross-cutting
research portfolio of innovative studies on the quality and durability of HIV treatment and prevention efforts, as
well as on co-infections and co-morbidities. The primary aims are: 1) to understand what it will take to end
AIDS in the Asia-Pacific; 2) to characterize what is stopping PLHIV in the region from thriving with HIV over a
lifetime; and 3) to improve implementation approaches to prevention and treatment interventions for HIV and
related conditions. The secondary aims are: 1) to more efficiently collect and curate data to optimize
research and maximize data utilization; and 2) to secure the next generation of Asia-Pacific HIV researchers
through training and mentorship. The proposed research will inform clinical practice and public health policy
through a combination of national, regional, and multiregional longitudinal cohort studies, registry and database
linkages, and priority sub-studies. Specifically, hypothesis-driven analyses of cohort data sources and data
registries will characterize HIV disease and a range of co-infections and co-morbidities in children,
adolescents, and adults, and study their impact on long-term HIV treatment durability and mortality. Analyses
will especially consider risks and outcomes of non-communicable diseases associated with HIV and aging.
Approaches to optimizing lung and anal cancer screening will be assessed. Studies focusing on young men
who have sex with men and transgender communities will characterize behaviors and co-infections that
increase HIV acquisition risk. To better understand the intersections between HIV and the use of alcohol,
tobacco, and other substances, cohort data collection will be expanded to capture a broader range of health
measurements and exposures to support analyses of physical and mental health outcomes. Investigators will
study implementation strategies for increasing uptake of, and adherence to, TB preventive therapy, mental
health care, and HIV pre-exposure prophylaxis. In addition, cohort research methods will be adapted to
optimize the balance between cohort size and data completeness, and improve data harmonizati...

## Key facts

- **NIH application ID:** 10410574
- **Project number:** 5U01AI069907-17
- **Recipient organization:** FOUNDATION FOR AIDS RESEARCH
- **Principal Investigator:** Matthew Law
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $3,084,111
- **Award type:** 5
- **Project period:** 2006-07-15 → 2026-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10410574

## Citation

> US National Institutes of Health, RePORTER application 10410574, IeDEA Asia-Pacific Research Collaboration (5U01AI069907-17). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10410574. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*